Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125421431 | 12542143 | 1 | I | 20160625 | 20160708 | 20160708 | EXP | CA-HQ SPECIALTY-CA-2016INT000478 | INTERCHEM | 64.00 | YR | F | Y | 85.00000 | KG | 20160708 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125421431 | 12542143 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 17.5 TO 25 MG (1 IN 1 W) | N | 201749 | |||||||||
| 125421431 | 12542143 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 17.5 TO 25 MG (1 IN 1 W) | N | 201749 | |||||||||
| 125421431 | 12542143 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 20 MG (20 MG, 1 IN 1 D) | N | 0 | 20 | MG | |||||||
| 125421431 | 12542143 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | N | 0 | |||||||||||
| 125421431 | 12542143 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG (400 MG, 1 IN 1 D) | N | 0 | 400 | MG | ||||||||
| 125421431 | 12542143 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | N | 0 | ||||||||||
| 125421431 | 12542143 | 7 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 0 | |||||||||
| 125421431 | 12542143 | 8 | SS | ENBREL | ETANERCEPT | 1 | N | 0 | |||||||||||
| 125421431 | 12542143 | 9 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | (2 G, 1 D) | N | 0 | 2 | G | |||||||
| 125421431 | 12542143 | 10 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | N | 0 | |||||||||
| 125421431 | 12542143 | 11 | SS | HUMIRA | ADALIMUMAB | 1 | N | 0 | |||||||||||
| 125421431 | 12542143 | 12 | SS | ORENCIA | ABATACEPT | 1 | UNK | N | 0 | ||||||||||
| 125421431 | 12542143 | 13 | SS | ORENCIA | ABATACEPT | 1 | N | 0 | |||||||||||
| 125421431 | 12542143 | 14 | SS | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | UNK | U | 0 | ||||||||||
| 125421431 | 12542143 | 15 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK, SINGLE | 0 | ||||||||||
| 125421431 | 12542143 | 16 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | Unknown | AT BEDTIME (20 MG) | 0 | ||||||||||
| 125421431 | 12542143 | 17 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | Unknown | BEDTIME (2 DOSAGE FORM, 1 D) | 0 | ||||||||||
| 125421431 | 12542143 | 18 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | (5 MG,1 D) | 0 | ||||||||||
| 125421431 | 12542143 | 19 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1000 MG (500 MG, 2 IN 1 D) | 0 | 500 | MG | ||||||||
| 125421431 | 12542143 | 20 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | ONCE NIGHTLY (1 MG) | U | 0 | 1 | MG | |||||||
| 125421431 | 12542143 | 21 | C | VAGIFEM | ESTRADIOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125421431 | 12542143 | 22 | C | LYRICA | PREGABALIN | 1 | Oral | 300 MG (150 MG, 2 IN 1 D) | U | 0 | 150 | MG | |||||||
| 125421431 | 12542143 | 23 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Unknown | (3.6 MG) | U | 0 | |||||||||
| 125421431 | 12542143 | 24 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125421431 | 12542143 | 25 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 125421431 | 12542143 | 26 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | Intramuscular | 1.3333 MG (40 MG, 1 IN 1 MO) | U | 0 | |||||||||
| 125421431 | 12542143 | 27 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | Subcutaneous | (1 MO) | U | 0 | |||||||||
| 125421431 | 12542143 | 28 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 125421431 | 12542143 | 29 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 125421431 | 12542143 | 30 | C | ACTONEL ONCE-A-WEEK | 2 | Unknown | 5 MG (35 MG, 1 IN 1 W) | U | 0 | 5 | MG | ||||||||
| 125421431 | 12542143 | 31 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125421431 | 12542143 | 32 | C | METHYLPREDNISOLONE ACETATE. | METHYLPREDNISOLONE ACETATE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125421431 | 12542143 | 1 | Rheumatoid arthritis |
| 125421431 | 12542143 | 2 | Spinal osteoarthritis |
| 125421431 | 12542143 | 3 | Rheumatoid arthritis |
| 125421431 | 12542143 | 4 | Spinal osteoarthritis |
| 125421431 | 12542143 | 5 | Rheumatoid arthritis |
| 125421431 | 12542143 | 6 | Spinal osteoarthritis |
| 125421431 | 12542143 | 7 | Rheumatoid arthritis |
| 125421431 | 12542143 | 8 | Spinal osteoarthritis |
| 125421431 | 12542143 | 9 | Rheumatoid arthritis |
| 125421431 | 12542143 | 10 | Rheumatoid arthritis |
| 125421431 | 12542143 | 11 | Spinal osteoarthritis |
| 125421431 | 12542143 | 12 | Rheumatoid arthritis |
| 125421431 | 12542143 | 13 | Spinal osteoarthritis |
| 125421431 | 12542143 | 14 | Rheumatoid arthritis |
| 125421431 | 12542143 | 15 | Rheumatoid arthritis |
| 125421431 | 12542143 | 16 | Pain |
| 125421431 | 12542143 | 17 | Insomnia |
| 125421431 | 12542143 | 18 | Type 2 diabetes mellitus |
| 125421431 | 12542143 | 20 | Product used for unknown indication |
| 125421431 | 12542143 | 21 | Product used for unknown indication |
| 125421431 | 12542143 | 22 | Pain |
| 125421431 | 12542143 | 23 | Product used for unknown indication |
| 125421431 | 12542143 | 24 | Product used for unknown indication |
| 125421431 | 12542143 | 25 | Product used for unknown indication |
| 125421431 | 12542143 | 26 | Pain |
| 125421431 | 12542143 | 27 | Insomnia |
| 125421431 | 12542143 | 29 | Product used for unknown indication |
| 125421431 | 12542143 | 30 | Product used for unknown indication |
| 125421431 | 12542143 | 31 | Product used for unknown indication |
| 125421431 | 12542143 | 32 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125421431 | 12542143 | HO |
| 125421431 | 12542143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125421431 | 12542143 | Blood pressure abnormal | |
| 125421431 | 12542143 | Carpal tunnel syndrome | |
| 125421431 | 12542143 | Drug ineffective | |
| 125421431 | 12542143 | Fibromyalgia | |
| 125421431 | 12542143 | General physical health deterioration | |
| 125421431 | 12542143 | Liver function test increased | |
| 125421431 | 12542143 | Neuropathy peripheral | |
| 125421431 | 12542143 | Osteoarthritis | |
| 125421431 | 12542143 | Osteopenia | |
| 125421431 | 12542143 | Radicular pain | |
| 125421431 | 12542143 | Rheumatoid arthritis | |
| 125421431 | 12542143 | Spinal column stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125421431 | 12542143 | 1 | 200711 | 201207 | 0 | |
| 125421431 | 12542143 | 2 | 2015 | 0 | ||
| 125421431 | 12542143 | 3 | 200706 | 200708 | 0 | |
| 125421431 | 12542143 | 5 | 200609 | 200802 | 0 | |
| 125421431 | 12542143 | 6 | 200803 | 201008 | 0 | |
| 125421431 | 12542143 | 9 | 200701 | 200706 | 0 | |
| 125421431 | 12542143 | 12 | 201412 | 0 | ||
| 125421431 | 12542143 | 15 | 201207 | 0 | ||
| 125421431 | 12542143 | 26 | 201605 | 0 | ||
| 125421431 | 12542143 | 27 | 201605 | 0 |